Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Breast Cancer · Prostate Cancer · UTHR

United Therapeutics Europe

United Therapeutics Europe Ltd

United Therapeutics Europe clinical programs — 199 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
Status
Public
HQ
1000 Spring Street, Silver Spring, Maryland 20910, US
Founded
1996
Employees
1,443
Programs
1032
Drugs
612
Patents
3720
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

United Therapeutics Europe projects

199 ClinicalTrials.gov programs sponsored by United Therapeutics Europe.

United Therapeutics Europe has 199 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

199 programs

Clinical programs

Page 4 of 5

  1. Rituximab

    United Therapeutics Europe Ltd

    Kidney Transplant Rejection

    phase 3 small molecule terminated

    1 trial

  2. Rituximab

    United Therapeutics Europe Ltd

    Follicular Lymphoma

    phase 3 small molecule completed

    1 trial

  3. Rivastigmine Transdermal System

    United Therapeutics Europe Ltd

    Parkinson Disease

    phase 3 small molecule completed

    1 trial

  4. SBRT

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 3 other active

    3 trials

  5. SR-A + Epratuzumab

    United Therapeutics Europe Ltd

    Acute Lymphoblastic Leukemia (ALL)

    phase 3 small molecule completed

    1 trial

  6. Standard of Care PO (oral) antibiotics

    United Therapeutics Europe Ltd

    Infections

    phase 3 small molecule active

    1 trial

  7. Standard treatment: Control arm

    United Therapeutics Europe Ltd

    Cervical Carcinoma

    phase 3 other active

    1 trial

  8. Sufentanil 30 MCG Sublingual Tablet

    United Therapeutics Europe Ltd

    Traumatic Injury

    phase 3 small molecule completed

    1 trial

  9. Surgery with an external ring fixator

    United Therapeutics Europe Ltd

    Severe Open Fractures of the Tibia (Shin) Bone

    phase 3 other completed

    1 trial

  10. TKI

    United Therapeutics Europe Ltd

    NSCLC

    phase 3 small molecule active

    1 trial

  11. TPOXX

    United Therapeutics Europe Ltd

    Smallpox

    phase 3 small molecule completed

    1 trial

  12. Tadalafil

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 3 small molecule completed

    1 trial

  13. Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg)

    United Therapeutics Europe Ltd

    Critical Illness

    phase 3 other active

    2 trials

  14. Tenofovir gel

    United Therapeutics Europe Ltd

    HIV Prevention

    phase 3 small molecule completed

    1 trial

  15. Teriparatide

    United Therapeutics Europe Ltd

    Stress Fracture

    phase 3 small molecule active

    1 trial

  16. Thalidomide

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 3 small molecule completed

    1 trial

  17. Tice® BCG (for intravesical use) BCG LIVE strain of the BCG (Merck) vaccine

    United Therapeutics Europe Ltd

    COVID-19

    phase 3 small molecule terminated

    1 trial

  18. Tobramycin Injection

    United Therapeutics Europe Ltd

    Wound Infection

    phase 3 small molecule active

    1 trial

  19. Tranexamic Acid

    United Therapeutics Europe Ltd

    Spinal Injuries

    phase 3 small molecule active

    1 trial

  20. Treatment group

    United Therapeutics Europe Ltd

    Post Operative Surgical Site Infection

    phase 3 small molecule completed

    1 trial

  21. Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)

    United Therapeutics Europe Ltd

    Nausea

    phase 3 small molecule active

    1 trial

  22. UB-421

    United Therapeutics Europe Ltd

    HIV-1 Infection

    phase 3 mab active

    4 trials

  23. UI022 or UI023 and co-administration of matching placebo

    United Therapeutics Europe Ltd

    Peripheral Arterial Disease

    phase 3 small molecule completed

    1 trial

  24. UI05MSP015CT

    United Therapeutics Europe Ltd

    Functional Dyspepsia

    phase 3 small molecule completed

    1 trial

  25. UT-15

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 3 small molecule completed

    1 trial

  26. UT-15C (treprostinil diolamine)

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 3 small molecule completed

    1 trial

  27. UT-15C SR

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 3 small molecule completed

    1 trial

  28. UT-15C SR

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 3 small molecule completed

    3 trials

  29. Venetoclax 400

    United Therapeutics Europe Ltd

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  30. Vitamin A

    United Therapeutics Europe Ltd

    Sepsis

    phase 3 other completed

    1 trial

  31. Warfarin

    United Therapeutics Europe Ltd

    Subsegmental Pulmonary Embolism Nos

    phase 3 small molecule active

    1 trial

  32. Wheat Soy Blend (WSB++)

    United Therapeutics Europe Ltd

    Stunting

    phase 3 other completed

    1 trial

  33. Zinc sulphate

    United Therapeutics Europe Ltd

    Diarrhea

    phase 3 other completed

    1 trial

  34. Zinc sulphate 20 mg

    United Therapeutics Europe Ltd

    Bronchiolitis

    phase 3 small molecule completed

    1 trial

  35. Zoledronic acid

    United Therapeutics Europe Ltd

    Osteoporosis

    phase 3 small molecule terminated

    1 trial

  36. abamectin and fenpyroximate

    United Therapeutics Europe Ltd

    Malaria

    phase 3 small molecule terminated

    1 trial

  37. asparaginase

    United Therapeutics Europe Ltd

    Lymphoma

    phase 3 small molecule active

    1 trial

  38. bLF (Bovine lactoferrin)

    United Therapeutics Europe Ltd

    Neonatal Sepsis

    phase 3 other active

    1 trial

  39. cisplatin

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 3 small molecule completed

    1 trial

  40. doxorubicin hydrochloride

    United Therapeutics Europe Ltd

    Stage III Bladder Cancer

    phase 3 small molecule completed

    1 trial

  41. educational internet site on prostate cancer screening

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 3 other completed

    1 trial

  42. gene expression analysis

    United Therapeutics Europe Ltd

    Kidney Cancer

    phase 3 gene therapy active

    1 trial

  43. intensity-modulated radiation therapy

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 other active

    1 trial

  44. lomustine

    United Therapeutics Europe Ltd

    Brain and Central Nervous System Tumors

    phase 3 small molecule completed

    1 trial

  45. low titer whole blood

    United Therapeutics Europe Ltd

    Hemorrhagic Shock

    phase 3 mab completed

    1 trial

  46. metformin hydrochloride

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  47. paclitaxel

    United Therapeutics Europe Ltd

    Germ Cell Tumor

    phase 3 small molecule active

    1 trial

  48. pegfilgrastim

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 mab active

    1 trial

Frequently asked questions

How many clinical projects does United Therapeutics Europe have?

199 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.